2,3-Dimethylbenzonitrile | CAS:5724-56-1

We serve 2,3-Dimethylbenzonitrile CAS:5724-56-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,3-Dimethylbenzonitrile

Chemical Name:2,3-Dimethylbenzonitrile
CAS.NO:5724-56-1
Synonyms:2,3-Dimethylbenzonitrile
Benzonitrile, 2,3-dimethyl-
dimethyl benzonitrile
2,3-dimethyl-benzonitrile
3-CYANO-O-XYLENE
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 241.7±9.0 °C at 760 mmHg
Melting Point 23-25°C
Molecular Formula C9H9N
Molecular Weight 131.174
Flash Point 99.9±11.2 °C
 
Specification:
Appearance:Yellow to brown liquid
Assay:≥95.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Medetomidine



Contact us for information like 2,3-Dimethylbenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-CYANO-O-XYLENE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-Dimethylbenzonitrile Use and application,3-CYANO-O-XYLENE technical grade,usp/ep/jp grade.


Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.5-Chloro-2-Fluoro-3-Methylpyridine manufacturer FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.2-chloro-3-isothiocyanatoprop-1-ene supplier It also said it would bar South Koreans from visiting China as tourists.1,4-Dioxaspiro[4.5]decan-8-one vendor It also said it would bar South Koreans from visiting China as tourists.In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.